Cargando…
Mechanisms of propranolol action in infantile hemangioma
Infantile hemangioma is a common tumor of infancy. Although most hemangiomas spontaneously regress, treatment is indicated based on complications, risk to organ development and function, and disfigurement. The serendipitous discovery of propranolol, a non-selective β-adrenergic receptor blocker, as...
Autores principales: | Kum, Jina JY, Khan, Zia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580045/ https://www.ncbi.nlm.nih.gov/pubmed/26413184 http://dx.doi.org/10.4161/19381980.2014.979699 |
Ejemplares similares
-
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis
por: Kum, Jina J.Y., et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)